CoChat

Body mass index and cancer risk in patients with type 2 diabetes: A dose-response meta-analysis of cohort studies

Open access

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Abstract

Although obesity has been associated with an increased cancer risk in the general population, the association in patients with type 2 diabetes (T2D) remains controversial. We conducted a dose–response meta-analysis of cohort studies of body mass index (BMI) and the risk of total and site-specific cancers in patients with T2D. A systematic literature search was conducted in PubMed, Scopus, and Medline until September 2020 for cohort studies on the association between BMI and cancer risk in patients with T2D. Summary relative risks (RRs) and 95% confidence intervals (CIs) were calculated using random effects models. Ten prospective and three retrospective cohort studies (3,345,031 participants and 37,412 cases) were included in the meta-analysis. Each 5-unit increase in BMI (kg/m 2) was associated with a 6% higher risk of total cancer (RR: 1.06, 95% CI 1.01, 1.10; I 2 = 55.4%, n = 6), and with a 12% increased risk in the analysis of breast cancer (RR: 1.12, 95% CI 1.05, 1.20; I 2 = 0%, n = 3). The pooled RRs showed no association with prostate cancer (RR: 1.02, 95% CI 0.92, 1.13; I 2 = 64.6%, n = 4), pancreatic cancer (RR: 0.97, 95% CI 0.84, 1.11; I 2 = 71%, n = 3), and colorectal cancer (RR: 1.05, 95% CI 0.98, 1.13; I 2 = 65.9%, n = 2). There was no indication of nonlinearity for total cancer (P non-linearity = 0.99), however, there was evidence of a nonlinear association between BMI and breast cancer (P non-linearity = 0.004) with steeper increases in risk from a BMI around 35 and above respectively. Higher BMI was associated with a higher risk of total, and breast cancer but not with risk of other cancers, in patients with T2D, however, further studies are needed before firm conclusions can be drawn.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-81671-0

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow diagram of the study selection process.
Figure 1 Flow diagram of the study selection process.CC BY · PubMed Central
Figure 2 Summary risk estimates of overall and different cancer sites for each 5-unit increase in body mass index in patients with T2D.
Figure 2 Summary risk estimates of overall and different cancer sites for each 5-unit increase in body mass index in patients with T2D.CC BY · PubMed Central
Figure 3 (A) Risk of total cancer associated with each 5-unit increase in body mass index in patients with T2D. The study-specific relative risk and 95% CI are represented by the black square and horizontal line, respectively; the area of the black square is proportional to the specific-study weight to the overall meta-analysis. The center of the open diamond presents the pooled RR and its width represents the pooled 95% CI. Weights are from the random-effects analysis. (B) Dose–response association of body mass index and total cancer risk in patients with T2D (Pnon-linearity = 0.99). (C) Risk of breast cancer associated with each 5-unit increase in body mass index in patients with T2D. The study-specific relative risk and 95% CI are represented by the black square and horizontal line, respectively; the area of the black square is proportional to the specific-study weight to the overall meta-analysis. The center of the open diamond presents the pooled RR and its width represents the pooled 95% CI. Weights are from the random-effects analysis. (D) Dose–response association of body mass index and breast cancer risk in patients with T2D (Pnon-linearity = 0.004).
Figure 3 (A) Risk of total cancer associated with each 5-unit increase in body mass index in patients with T2D. The study-specific relative risk and 95% CI are represented by the black square and horizontal line, respectively; the area of the black square is proportional to the specific-study weight to the overall meta-analysis. The center of the open diamond presents the pooled RR and its width represents the pooled 95% CI. Weights are from the random-effects analysis. (B) Dose–response association of body mass index and total cancer risk in patients with T2D (Pnon-linearity = 0.99). (C) Risk of breast cancer associated with each 5-unit increase in body mass index in patients with T2D. The study-specific relative risk and 95% CI are represented by the black square and horizontal line, respectively; the area of the black square is proportional to the specific-study weight to the overall meta-analysis. The center of the open diamond presents the pooled RR and its width represents the pooled 95% CI. Weights are from the random-effects analysis. (D) Dose–response association of body mass index and breast cancer risk in patients with T2D (Pnon-linearity = 0.004).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 59 references

Research works printed but not linked: 1

  1. Sterne, J.A.C., Moher, D. Chapter 10: addressing reporting biases. Cochrane handbook for systematic reviews of intervention. Version 5.1.0 (Updated march 2011) edition. Edited by: Higgins JPT, Green S. 2011, The Cochrane Collaboration.

Cited by

See all 27

Metadata

Authors
Soltani, S., Abdollahi, S., Aune, D., & Jayedi, A.
Affiliations
  • Shahid Sadoughi University of Medical Sciences and Health Services (IR)
  • North Khorasan University of Medical Sciences (IR)
  • Oslo University Hospital (NO)
  • Semnan University of Medical Sciences (IR)
Corresponding author
Jayedi, Ahmad
Venue
Scientific Reports
Published
2021-01-28
Volume
11
Issue
1
Pages
2479-2479
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3123839075
Cited by
22
References
59
Citations by year
2026: 2 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 3 · 2021: 4
FWCI
0.51
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
University of Leeds
Topics
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
type 2 diabetes, cancer risk, obesity, breast cancer, prostate cancer, pancreatic cancer, colorectal cancer, dose-response relationship, nonlinear relationship, site-specific cancer risk
MeSH terms
Diabetes Mellitus, Type 2, Female, Humans, Male, Neoplasms, Risk Factors, Body Mass Index, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Body mass index and cancer risk in patients with type 2 diabetes: A dose-response meta-analysis of cohort studies. https://app.cochat.ai/papers/10.1038/s41598-021-81671-0
The paper
Soltani, S., Abdollahi, S., Aune, D., & Jayedi, A. (2021). Body mass index and cancer risk in patients with type 2 diabetes: A dose-response meta-analysis of cohort studies. Scientific Reports. https://doi.org/10.1038/s41598-021-81671-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.